Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Opsens Inc (OPS.TO)

Opsens Inc (OPS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
HAEMONETICS COMPLETES ACQUISITION OF OPSENS Newswire.ca - Tue Dec 12, 2023

/CNW/ - OpSens Inc. ("OpSens" or the "Corporation") (TSX: OPS) (OTCQX: OPSSF), a medical device cardiology-focused company delivering innovative solutions...

OPSSF : 2.1389 (+0.64%)
HAE : 91.06 (+0.51%)
OPS.TO : 2.90 (unch)
Stocks in play: OpSens Inc. Baystreet - Fri Dec 8, 2023

Announces that the Superior Court of Québec issued a final order today in connection with the previously ...

HAE : 91.06 (+0.51%)
OPS.TO : 2.90 (unch)
OPSENS RECEIVES FINAL ORDER FOR ARRANGEMENT WITH HAEMONETICS Newswire.ca - Fri Dec 8, 2023

/CNW/ - OpSens Inc. ("OpSens" or the "Corporation") (TSX: OPS) (OTCQX: OPSSF), a medical device cardiology-focused company delivering innovative solutions...

OPSSF : 2.1389 (+0.64%)
HAE : 91.06 (+0.51%)
OPS.TO : 2.90 (unch)
OPSENS' SHAREHOLDERS APPROVE ARRANGEMENT WITH HAEMONETICS Newswire.ca - Fri Dec 1, 2023

/CNW/ - OpSens Inc. ("OpSens" or the "Corporation") (TSX: OPS) (OTCQX: OPSSF), a medical device cardiology-focused company delivering innovative solutions...

OPSSF : 2.1389 (+0.64%)
HAE : 91.06 (+0.51%)
OPS.TO : 2.90 (unch)
OPSENS OBTAINS REGULATORY CLEARANCE OF ARRANGEMENT IN THE UNITED STATES AND CANADA; REGULATORY APPROVALS CONDITION SATISFIED Newswire.ca - Tue Nov 28, 2023

All amounts in this press release are in Canadian dollars. Clearance under both the United States Hart-Scott-Rodino Antitrust Improvements Act of 1976 and the...

OPSSF : 2.1389 (+0.64%)
HAE : 91.06 (+0.51%)
OPS.TO : 2.90 (unch)
OPSENS ANNOUNCES FOURTH QUARTER AND FISCAL YEAR 2023 FINANCIAL RESULTS Newswire.ca - Wed Nov 22, 2023

/CNW/ - OpSens Inc. ("OpSens" or the "Company") (TSX: OPS) (OTCQX: OPSSF), a medical device cardiology-focused company delivering innovative solutions based on...

OPSSF : 2.1389 (+0.64%)
OPS.TO : 2.90 (unch)
INDEPENDENT PROXY ADVISORY FIRM ISS RECOMMENDS SHAREHOLDERS VOTE "FOR" OPSENS INC. PLAN OF ARRANGEMENT WITH HAEMONETICS CORPORATION Newswire.ca - Mon Nov 13, 2023

All amounts in this press release are in Canadian dollars. Leading independent proxy advisor says cash offer provides meaningful 50.3% premium to OpSens Inc.'s...

OPSSF : 2.1389 (+0.64%)
HAE : 91.06 (+0.51%)
OPS.TO : 2.90 (unch)
OPSENS RECEIVES INTERIM ORDER AND FILES MANAGEMENT INFORMATION CIRCULAR IN CONNECTION WITH SPECIAL MEETING OF SHAREHOLDERS Newswire.ca - Thu Nov 2, 2023

/CNW/ - OpSens Inc. ("OpSens" or the "Corporation") (TSX: OPS) (OTCQX: OPSSF) announces that the Québec Superior Court (the "Court") issued an interim order...

OPSSF : 2.1389 (+0.64%)
HAE : 91.06 (+0.51%)
OPS.TO : 2.90 (unch)
OPSENS ANNOUNCES THE POSITIVE CLINICAL RESULTS FROM THE SAFE-TAVI STUDY WITH SAVVYWIRE IN EUROPE Newswire.ca - Mon Oct 23, 2023

/CNW/ - OpSens Inc. ("OpSens" or the "Company") (TSX: OPS) (OTCQX: OPSSF), a medical device cardiology-focused company delivering innovative solutions based on...

MDT : 78.70 (+0.31%)
OPSSF : 2.1389 (+0.64%)
OPS.TO : 2.90 (unch)
OpSens to Participate in the Transcatheter Cardiovascular Therapeutics Conference (TCT) in San Francisco October 23 - 26, 2023 Newswire.ca - Tue Oct 17, 2023

/CNW/ - OpSens Inc. ("OpSens" or the "Company") (TSX: OPS) (OTCQX: OPSSF), a medical device cardiology-focused company delivering innovative solutions based on...

OPSSF : 2.1389 (+0.64%)
OPS.TO : 2.90 (unch)

Barchart Exclusives

Up 128% YTD, Should You Still Invest in Nvidia Stock? Barchart - Sat Jul 27, 10:45AM CDT
For investors looking to capitalize on a leader in the AI revolution, Nvidia remains a compelling opportunity with a promising outlook. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot